Mir-23a and mir-181b serum levels in irritable bowel syndrome and colorectal cancer – A pilot study

Mir-23a and mir-181b serum levels in irritable bowel syndrome and colorectal cancer – A pilot study

An emerging evidence suggests that microRNAs (miRNAs) may be reliable biomarkers for inflammation or oncogenesis. The aim of this study was to investigate the diagnostic value of miR-23a and miR-181b in patients with irritable bowel syndrome (IBS) and patients with colorectal cancer (CRC) vs. healt...

Full description

Bibliographic Details
Main Authors: Alexandra Chira, Mihai-Stefan Muresan, Cornelia Braicu, Liviuta Budisan, Lajos Raduly, Romeo Ioan Chira, Dan Lucian Dumitrascu, Ioana Berindan-Neagoe
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2019-12-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
Biomarker
colorectal cancer
irritable bowel syndrome
microRNA
miRNA
miR-23a
Online Access:https://bjbms.org/ojs/index.php/bjbms/article/view/4392

Internet

https://bjbms.org/ojs/index.php/bjbms/article/view/4392

Similar Items